JP2002501045A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501045A5 JP2002501045A5 JP2000528536A JP2000528536A JP2002501045A5 JP 2002501045 A5 JP2002501045 A5 JP 2002501045A5 JP 2000528536 A JP2000528536 A JP 2000528536A JP 2000528536 A JP2000528536 A JP 2000528536A JP 2002501045 A5 JP2002501045 A5 JP 2002501045A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- composition
- azetidine
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 38
- -1 R 2 is H Chemical group 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 206010053164 Alcohol withdrawal syndrome Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000008238 Muscle Spasticity Diseases 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 208000029650 alcohol withdrawal Diseases 0.000 description 2
- 208000015114 central nervous system disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000036640 muscle relaxation Effects 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 238000009101 premedication Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 208000018198 spasticity Diseases 0.000 description 2
- 201000009032 substance abuse Diseases 0.000 description 2
- 231100000736 substance abuse Toxicity 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 0 **C(N(C1)CC1OC(*)*)=O Chemical compound **C(N(C1)CC1OC(*)*)=O 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- UHLCPOAXXUWEHE-UHFFFAOYSA-N 3-[(4-chlorophenyl)methoxy]-n-prop-2-enylazetidine-1-carboxamide Chemical compound C1=CC(Cl)=CC=C1COC1CN(C(=O)NCC=C)C1 UHLCPOAXXUWEHE-UHFFFAOYSA-N 0.000 description 1
- UJOGKJWHLZMYBI-UHFFFAOYSA-N 3-[(4-fluorophenyl)methoxy]-n-prop-2-enylazetidine-1-carboxamide Chemical compound C1=CC(F)=CC=C1COC1CN(C(=O)NCC=C)C1 UJOGKJWHLZMYBI-UHFFFAOYSA-N 0.000 description 1
- DBBPOGGTCAKHPS-UHFFFAOYSA-N 3-[1-[3-(trifluoromethyl)phenyl]ethoxy]azetidine-1-carboxamide Chemical compound C=1C=CC(C(F)(F)F)=CC=1C(C)OC1CN(C(N)=O)C1 DBBPOGGTCAKHPS-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9801500.1A GB9801500D0 (en) | 1998-01-23 | 1998-01-23 | Chemical compounds - II |
| GB9801500.1 | 1998-01-23 | ||
| GB9824457.7 | 1998-11-06 | ||
| GBGB9824457.7A GB9824457D0 (en) | 1998-11-06 | 1998-11-06 | Chemical compounds II |
| PCT/GB1999/000219 WO1999037612A1 (en) | 1998-01-23 | 1999-01-22 | Azetidinecarboxamide derivatives for treating cns disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002501045A JP2002501045A (ja) | 2002-01-15 |
| JP2002501045A5 true JP2002501045A5 (enExample) | 2006-03-02 |
| JP4542263B2 JP4542263B2 (ja) | 2010-09-08 |
Family
ID=26313010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528536A Expired - Lifetime JP4542263B2 (ja) | 1998-01-23 | 1999-01-22 | Ｃｎｓ障害を処置するためのアゼチジンカルボキサミド誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6403574B1 (enExample) |
| EP (1) | EP1049672B1 (enExample) |
| JP (1) | JP4542263B2 (enExample) |
| AT (1) | ATE250027T1 (enExample) |
| AU (1) | AU2287499A (enExample) |
| DE (1) | DE69911373T2 (enExample) |
| DK (1) | DK1049672T3 (enExample) |
| ES (1) | ES2207171T3 (enExample) |
| PT (1) | PT1049672E (enExample) |
| WO (1) | WO1999037612A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
| EP1617839B1 (en) * | 2003-05-01 | 2008-06-18 | Vernalis Research Limited | The use of azetidinecarboxamide derivatives in therapy |
| EP1618105A1 (en) * | 2003-05-01 | 2006-01-25 | Vernalis Research Limited | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| CA2524251A1 (en) * | 2003-05-01 | 2004-11-11 | Vernalis Research Limited | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| US11141404B1 (en) * | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
| AU2022362107A1 (en) | 2021-10-11 | 2024-05-02 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB872447A (en) * | 1958-12-23 | 1961-07-12 | Lepetit Spa | 1-carbamyl-3-substituted azetidines |
| US4226861A (en) | 1978-04-18 | 1980-10-07 | A. H. Robins Company, Inc. | N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides |
| IL68699A (en) * | 1982-08-19 | 1986-08-31 | Robins Co Inc A H | 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them |
| US4505907A (en) | 1982-09-02 | 1985-03-19 | A. H. Robins Company, Inc. | N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides |
| IE58943B1 (en) * | 1985-02-28 | 1993-12-01 | Robins Co Inc A H | 3-Aryloxy-azetidine-carboxamides |
| US4956359A (en) * | 1985-02-28 | 1990-09-11 | A. H. Robins Company, Inc. | 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics |
-
1999
- 1999-01-22 DE DE69911373T patent/DE69911373T2/de not_active Expired - Lifetime
- 1999-01-22 PT PT99902658T patent/PT1049672E/pt unknown
- 1999-01-22 EP EP99902658A patent/EP1049672B1/en not_active Expired - Lifetime
- 1999-01-22 WO PCT/GB1999/000219 patent/WO1999037612A1/en not_active Ceased
- 1999-01-22 JP JP2000528536A patent/JP4542263B2/ja not_active Expired - Lifetime
- 1999-01-22 ES ES99902658T patent/ES2207171T3/es not_active Expired - Lifetime
- 1999-01-22 AT AT99902658T patent/ATE250027T1/de not_active IP Right Cessation
- 1999-01-22 DK DK99902658T patent/DK1049672T3/da active
- 1999-01-22 US US09/600,628 patent/US6403574B1/en not_active Expired - Lifetime
- 1999-01-22 AU AU22874/99A patent/AU2287499A/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3244540B2 (ja) | トラマドール材料とコデイン、オキシコドン又はヒドロコドンのいずれかを含む組成物及びその利用 | |
| JP2007508361A5 (enExample) | ||
| KR100236562B1 (ko) | 트라마돌 및 비-스테로이드성 소염제를 함유하는 조성물 | |
| RU2470011C2 (ru) | Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов | |
| JP2007508360A5 (enExample) | ||
| RU98105169A (ru) | Производные 8-азабицикло[3.2.1]окт-2-ена, их получение и применение | |
| JP2002508364A5 (enExample) | ||
| JP2005539068A5 (enExample) | ||
| JP2008509187A5 (enExample) | ||
| DK1362039T3 (da) | Heterocykliske, substituerede carbonylderivater og deres anvendelse som dopamin D3-receptorligander | |
| RU2003121307A (ru) | (диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета | |
| JP2008535835A5 (enExample) | ||
| JP2005508872A5 (enExample) | ||
| JP2002501045A5 (enExample) | ||
| JP2005500370A5 (enExample) | ||
| US10682343B2 (en) | Snoring treatment | |
| RU2006110545A (ru) | Новое медицинское применение избирательных антагонистов св1-рецептора | |
| JP2014504648A5 (enExample) | ||
| JP2013536206A5 (enExample) | ||
| JP2003529597A5 (enExample) | ||
| JPH02138214A (ja) | 不安を治療する方法 | |
| JP2002501046A5 (enExample) | ||
| JP2004514709A5 (enExample) | ||
| JP2004526721A5 (enExample) | ||
| JP2005534668A5 (enExample) |